Madison Investments, an investment advisor, recently published its first-quarter 2026 investor letter for the “Madison Large Cap Fund”. The fund experienced a decline of 2.7% in the quarter, outperforming the S&P 500’s -4.33% return. The primary focus of the fund is on long-term capital appreciation. The quarter witnessed a shift in the equity market away from mega-cap technology stocks towards physical economy stocks, driven by concerns of AI disruption. Additionally, escalating commodity prices due to the Middle East conflict reignited inflation worries, benefiting sectors like Energy, Materials, Utilities, Staples, and Real Estate, which the Fund does not typically invest in, thereby impacting its relative performance. To gain insights into their key selections for 2026, let’s review the Fund’s top five holdings.
One of the highlighted companies in the first-quarter 2026 investor letter by Madison Large Cap Fund is Danaher Corporation (NYSE:DHR). Danaher Corporation is a healthcare and life science tools company that operates through Biotechnology, Life Sciences, and Diagnostics segments. As of June 12, 2026, Danaher Corporation closed at $180.10 per share, with a one-month return of 9.78% and a 10.55% decrease over the past 52 weeks. The company boasts a market capitalization of $127.47 billion.
The investor letter stated the following regarding Danaher Corporation in Q1 2026: “Our two life science tools investments, Danaher Corporation (NYSE:DHR) and Agilent, round out the top five detractors. Both companies reported results broadly consistent with expectations. However, while each respective company’s outlook for 2026 calls for continued end market recovery, it was at a slower pace than investors hoped. Furthermore, investors appear to also have ascribed some level of “AI risk” to these companies on the belief that AI technology could enable customers to simulate research experiments, thus reducing the need to purchase instruments and consumables used for physical experiments in the lab. We believe that there is a low likelihood that this will ultimately occur, and even if it did happen, early-stage R&D activity represents a very small percentage of Agilent and Danaher’s revenue.”
Danaher Corporation currently holds the 24th spot on the list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to data, 110 hedge fund portfolios held Danaher Corporation at the end of Q1, up from 125 in the previous quarter. While the potential of Danaher Corporation as an investment is acknowledged, certain AI stocks are believed to offer greater upside potential and carry less downside risk. For those seeking an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, a free report on the best short-term AI stock is available.
In conclusion, Madison Investments’ first-quarter 2026 investor letter sheds light on their investment strategies and key holdings, including Danaher Corporation. Despite the challenges faced in the market, the Fund remains optimistic about its long-term growth prospects.
